Nevro Corp. is a medical device company which focuses on providing products for the patients suffering from chronic pain. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Company sells its products through its direct sales force, and a network of sales agents and independent distributors.

Type
Public
HQ
Redwood City, US
Founded
2006
Size (employees)
518 (est)
Website
nevro.com
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US
Report incorrect company information

Nevro Corp. Office Locations

Nevro Corp. has an office in Redwood City
Redwood City, US (HQ)
1800 Bridge Parkway
Show all (1)
Report incorrect company information

Nevro Corp. Financials and Metrics

Nevro Corp. Financials

Nevro Corp.'s revenue was reported to be $228.50 m in FY, 2016 which is a 228.3% increase from the previous period.
USD

Revenue (Q2, 2017)

78 m

Gross profit (Q2, 2017)

53.9 m

Gross profit margin (Q2, 2017), %

69.1%

Net income (Q2, 2017)

(11.6 m)

EBIT (Q2, 2017)

(9.9 m)

Market capitalization (20-Apr-2018)

2.7 b

Cash (30-Jun-2017)

24.9 m

EV

2.8 b
Nevro Corp.'s current market capitalization is $2.7 b.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

32.6 m69.6 m228.5 m

Revenue growth, %

114%228%

Cost of goods sold

11.3 m28.1 m75.4 m

Gross profit

21.3 m41.5 m153.1 m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

8.7 m9.7 m11.4 m15.4 m41.7 m55.4 m60.9 m68.4 m78 m

Cost of goods sold

2.7 m3.9 m5.5 m6 m15.7 m18.8 m19.2 m22.1 m24.1 m

Gross profit

5.9 m5.8 m5.9 m9.4 m26 m36.6 m41.7 m46.4 m53.9 m

Gross profit Margin, %

68%60%52%61%62%66%68%68%69%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

25.3 m87 m41.4 m

Accounts Receivable

22.5 m52.8 m

Inventories

62.4 m85.2 m

Current Assets

201.1 m282.6 m420.3 m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

14.5 m22 m58.7 m87.6 m48.8 m50.7 m42.7 m19.2 m24.9 m

Inventories

12.1 m18.2 m26.4 m42.7 m67.6 m68.1 m73.4 m84.7 m87 m

Current Assets

53.5 m187.8 m291.5 m279.2 m265.9 m402.5 m408.9 m407.4 m410.3 m

PP&E

289 k1.2 m2.8 m5.7 m5.9 m6.7 m7.6 m7.4 m7.2 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(30.7 m)(67.4 m)(31.8 m)

Depreciation and Amortization

96 k614 k1.7 m

Inventories

(5.5 m)(49.4 m)(27 m)

Accounts Payable

1.3 m17.1 m(5.6 m)
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(7.9 m)(14.1 m)(19.7 m)(19.5 m)(9.3 m)(8.8 m)(3.9 m)(14.5 m)

Inventories

67.6 m68.1 m73.4 m84.7 m

Accounts Payable

3.5 m8.2 m7.3 m12.9 m11.8 m13.1 m13.1 m12.1 m
USDY, 2017

EV/EBIT

-280.5 x

Financial Leverage

1.7 x
Show all financial metrics

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16
Show all operating metrics
Report incorrect company information